Following are answers to some of the questions asked by journalists. For more information about our research, pipeline and products, please visit the pages within this site.
What is Kadmon?
Kadmon is a biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of significant unmet medical need.
Where is Kadmon located?
Kadmon is headquartered in New York, NY. We have commercial operations in Warrendale, PA, clinical operations in Cambridge, MA, and research and development operations in Monmouth Junction, NJ.
What are Kadmon’s therapeutic focus areas?
We have assembled a diversified portfolio of novel drug candidates in autoimmune and fibrotic diseases, oncology and genetic diseases.
What products does Kadmon market?
Kadmon currently markets and distributes a portfolio of branded generic ribavirin products for chronic hepatitis C virus (HCV) infection. Additionally, Kadmon Pharmaceuticals co-promotes and distributes products in a variety of therapeutic areas, including those indicated for the management of rare diseases. Please visit our Products page for a full listing of our product offerings.
I am a reporter. Whom do I contact for more information about Kadmon?
Please contact Media Relations at 212.308.6000 or firstname.lastname@example.org.